Qube Research & Technologies Ltd - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 125 filers reported holding ZIOPHARM ONCOLOGY INC in Q4 2022. The put-call ratio across all filers is 0.04 and the average weighting 0.0%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q3 2023$233
-99.3%
1,766
-96.7%
0.00%
Q4 2022$34,610
-86.7%
53,320
-64.8%
0.00%
-100.0%
Q3 2022$260,000
+45.3%
151,370
+5.1%
0.00%
+100.0%
Q2 2022$179,000
-56.8%
144,025
-62.1%
0.00%
-66.7%
Q4 2021$414,000
+226.0%
379,766
+689.6%
0.00%
+200.0%
Q2 2021$127,000
+28.3%
48,099
+22.9%
0.00%0.0%
Q4 2020$99,000
+37.5%
39,141
+32.7%
0.00%
-66.7%
Q1 2020$72,00029,4880.00%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q4 2022
NameSharesValueWeighting ↓
DISCOVERY CAPITAL MANAGEMENT, LLC / CT 15,461,829$2,037,8690.36%
MSD Partners, L.P. 15,151,516$1,996,9700.16%
MSD Partners, L.P. 7,575,758$998,4850.08%
MAGNOLIA CAPITAL ADVISORS LLC 865,938$65,5520.03%
Allred Capital Management, LLC 253,000$33,3450.02%
CHIRON CAPITAL MANAGEMENT, LLC 77,023$10,1520.01%
Boxer Capital, LLC 1,100,000$144,9800.01%
GSA CAPITAL PARTNERS LLP 569,566$750.01%
Sugarloaf Wealth Management, LLC 75,500$9,9510.00%
Owen LaRue, LLC 11,825$1,5590.00%
View complete list of ZIOPHARM ONCOLOGY INC shareholders